187 related articles for article (PubMed ID: 11468302)
1. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.
Sills GJ; Patsalos PN; Butler E; Forrest G; Ratnaraj N; Brodie MJ
Neurology; 2001 Jul; 57(2):196-200. PubMed ID: 11468302
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
[TBL] [Abstract][Full Text] [Related]
3. Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA.
Izumi Y; Ishikawa M; Benz AM; Izumi M; Zorumski CF; Thio LL
Epilepsia; 2004 Sep; 45(9):1043-8. PubMed ID: 15329067
[TBL] [Abstract][Full Text] [Related]
4. Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices.
Köhling R; König K; Lücke A; Mayer T; Wolf P; Speckmann EJ
Epilepsia; 2002 Dec; 43(12):1455-61. PubMed ID: 12460245
[TBL] [Abstract][Full Text] [Related]
5. Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes.
Leach JP; Sills GJ; Majid A; Butler E; Carswell A; Thompson GG; Brodie MJ
Seizure; 1996 Sep; 5(3):229-34. PubMed ID: 8902926
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex.
Leach JP; Sills GJ; Butler E; Forrest G; Thompson GG; Brodie MJ
Gen Pharmacol; 1997 May; 28(5):715-9. PubMed ID: 9184808
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin, tiagabine, and visual fields.
Lawden MC
J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):286. PubMed ID: 12588906
[No Abstract] [Full Text] [Related]
8. Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.
Walters DC; Jansen EEW; Ainslie GR; Salomons GS; Brown MN; Schmidt MA; Roullet JB; Gibson KM
Pharmacol Res Perspect; 2019 Feb; 7(1):e00456. PubMed ID: 30631446
[TBL] [Abstract][Full Text] [Related]
9. Ethical dilemmas of potential adverse events.
Beran RG
Med Law; 2001; 20(3):385-91. PubMed ID: 11713837
[TBL] [Abstract][Full Text] [Related]
10. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.
Luszczki JJ; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358
[TBL] [Abstract][Full Text] [Related]
11. Concentric visual field restriction under vigabatrin therapy: extent depends on the duration of drug intake.
Toggweiler S; Wieser HG
Seizure; 2001 Sep; 10(6):420-3. PubMed ID: 11700995
[TBL] [Abstract][Full Text] [Related]
12. A controlled study comparing visual function in patients treated with vigabatrin and tiagabine.
Krauss GL; Johnson MA; Sheth S; Miller NR
J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):339-43. PubMed ID: 12588920
[TBL] [Abstract][Full Text] [Related]
13. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin-associated visual field defects in children.
Russell-Eggitt IM; Mackey DA; Taylor DS; Timms C; Walker JW
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
[TBL] [Abstract][Full Text] [Related]
15. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
16. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
Moseng L; Sæter M; Mørch-Johnsen GH; Hoff JM; Gajda A; Brodtkorb E; Midelfart A
Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
[TBL] [Abstract][Full Text] [Related]
17. Visual fields and tiagabine: a quandary.
Kaufman KR; Lepore FE; Keyser BJ
Seizure; 2001 Oct; 10(7):525-9. PubMed ID: 11749112
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of tiagabine.
Kälviäinen R
Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
Sills GJ
Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
[TBL] [Abstract][Full Text] [Related]
20. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
